Predictive genetic markers in neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: a long way to go. Review of the literature

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Pharmacogenomics Journal

• Publication date

  2017-06-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/tpj.2017.25PMID 28607505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Genetic prediction of long-term survival after neoadjuvant chemoradiation in locally advanced esophageal cancer

  2016cited by this paper
• Low MiR-187 Expression Promotes Resistance to Chemoradiation Therapy In Vitro and Correlates with Treatment Failure in Patients with Esophageal Adenocarcinoma

  2016cited by this paper
• MiRNA Expression Analysis of Pretreatment Biopsies Predicts the Pathological Response of Esophageal Squamous Cell Carcinomas to Neoadjuvant Chemoradiotherapy

  2016cited by this paper
• TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

  2015cited by this paper
• Gene expression analysis of pretreatment biopsies predicts the pathological response of esophageal squamous cell carcinomas to neo-chemoradiotherapy.

  2014cited by this paper
• Homozygous GNAS 393C-Allele Carriers with Locally Advanced Esophageal Cancer Fail to Benefit from Platinum-Based Preoperative Chemoradiotherapy

  2014cited by this paper
• A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma

  2014cited by this paper
• Neoadjuvant therapy with weekly docetaxel and cisplatin, 5‐fluorouracil continuous infusion, and concurrent radiotherapy in patients with locally advanced esophageal cancer produced a high percentage of long‐lasting pathological complete response

  2013cited by this paper
• MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR‐192 in prediction of multimodality therapy response

  2013cited by this paper
• The Survival Impact of XPA and XPC Genetic Polymorphisms on Patients with Esophageal Squamous Cell Carcinoma

  2013cited by this paper
• Roles of thymidylate synthase and dihydropyrimidine dehydrogenase expression in blood as predictors of response to multimodal therapy in esophageal cancer.

  2012cited by this paper
• MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy.

  2012cited by this paper
• MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma

  2012cited by this paper
• Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis.

  2011cited by this paper
• Impact of ABCB1 C3435T polymorphism on lymph node regression in multimodality treatment of locally advanced esophageal cancer.

  2011cited by this paper
• Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Esophagus: ERCC1 Gene Polymorphisms for Prediction of Response and Prognosis

  2011cited by this paper
• TaqMan low-density arrays and analysis by artificial neuronal networks predict response to neoadjuvant chemoradiation in esophageal cancer.

  2010cited by this paper
• Prognostic Biomarkers for Esophageal Adenocarcinoma Identified by Analysis of Tumor Transcriptome

  2010cited by this paper
• CUL2 and STK11 as novel response-predictive genes for neoadjuvant radiochemotherapy in esophageal cancer.

  2010cited by this paper
• Gene Expression Analysis of Diagnostic Biopsies Predicts Pathological Response to Neoadjuvant Chemoradiotherapy of Esophageal Cancer

  2009cited by this paper
• Excision-repair cross-complementing 1 predicts response to cisplatin-based neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.

  2009cited by this paper
• Histological type of esophageal cancer might affect response to neo-adjuvant radiochemotherapy and subsequent prognosis.

  2009cited by this paper
• ERCC1 and XRCC1 Gene Polymorphisms Predict Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer

  2009cited by this paper
• MicroRNA Expression in Squamous Cell Carcinoma and Adenocarcinoma of the Esophagus: Associations with Survival

  2009cited by this paper
• A meta-analysis of DNA repair gene XPC polymorphisms and cancer risk

  2008cited by this paper
• Pretreatment Gene Expression Profiles Can Be Used to Predict Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer

  2007cited by this paper
• Decreased Expression of Gene Cluster at Chromosome 1q21 Defines Molecular Subgroups of Chemoradiotherapy Response in Esophageal Cancers

  2007cited by this paper
• Favorable Genetic Polymorphisms Predictive of Clinical Outcome of Chemoradiotherapy for Stage II/III Esophageal Squamous Cell Carcinoma in Japanese

  2007cited by this paper
• Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

  2007cited by this paper
• Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer.

  2006cited by this paper
• Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?

  2006cited by this paper
• Gene expression profiling of localized esophageal carcinomas: association with pathologic response to preoperative chemoradiation.

  2006cited by this paper
• Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours.

  2006cited by this paper
• The T393C Polymorphism of the Gαs Gene (GNAS1) Is a Novel Prognostic Marker in Bladder Cancer

  2005cited by this paper
• XPA, haplotypes, and risk of basal and squamous cell carcinoma.

  2005cited by this paper
• Polymorphisms of glutathione S-transferases (GST) and thymidylate synthase (TS) – novel predictors for response and survival in gastric cancer patients

  2005cited by this paper
• The T393C polymorphism of the G alpha s gene (GNAS1) is a novel prognostic marker in bladder cancer.

  2005cited by this paper
• Quantitative c-erbB-2 but not c-erbB-1 mRNA expression is a promising marker to predict minor histopathologic response to neoadjuvant radiochemotherapy in oesophageal cancer

  2004cited by this paper
• High Specificity of Quantitative Excision Repair Cross-Complementing 1 Messenger RNA Expression for Prediction of Minor Histopathological Response to Neoadjuvant Radiochemotherapy in Esophageal Cancer

  2004cited by this paper
• Identification and functional analysis of single nucleotide polymorphism in the tandem repeat sequence of thymidylate synthase gene.

  2003cited by this paper
• Biological and clinical implications of the MTHFR C677T polymorphism.

  2001cited by this paper
• Identification of four single nucleotide polymorphisms in DNA repair genes: XPA and XPB (ERCC3) in Polish population

  2000cited by this paper
• Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene.

  2000cited by this paper
• Prognostic Value of p53, Glutathione S-Transferase π, and Thymidylate Synthase for Neoadjuvant Cisplatin-based Chemotherapy in Head and Neck Cancer

  1999cited by this paper
• Prognostic value of p53, glutathione S-transferase pi, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer.

  1999cited by this paper
• Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription

  1998cited by this paper
• Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S-Transferase Pi Gene Variants

  1997cited by this paper
• Molecular Cloning, Characterization, and Expression in Escherichia coli of Full-length cDNAs of Three Human Glutathione S -Transferase Pi Gene Variants EVIDENCE FOR DIFFERENTIAL CATALYTIC ACTIVITY OF THE ENCODED PROTEINS*

  1997cited by this paper
• Functional analysis and DNA polymorphism of the tandemly repeated sequences in the 5'-terminal regulatory region of the human gene for thymidylate synthase.

  1995cited by this paper

• Integrating MR radiomics and dynamic hematological factors predicts pathological response to neoadjuvant chemoradiotherapy in esophageal cancer

  2024cites this paper
• The predictive value of microRNAs for pathological response after neoadjuvant treatment in esophageal squamous cell carcinoma: a systematic review

  2021cites this paper
• MMS22L Expression as a Predictive Biomarker for the Efficacy of Neoadjuvant Chemoradiotherapy in Oesophageal Squamous Cell Carcinoma

  2021cites this paper
• Real-world Scenario: CROSS Regimen as Preoperative Therapy for Oesophageal Squamous Cell Carcinoma

  2020cites this paper
• Consensus statement of the Hellenic and Cypriot Oesophageal Cancer Study Group on the diagnosis, staging and management of oesophageal cancer

  2019cites this paper
• Bioinformatics-based identification of differentiated expressed microRNA in esophageal squamous cell carcinoma

  2018cites this paper